Modulating intracellular oxidative stress via engineered nanotherapeutics
Zepbound and Wegovy have demonstrated superior weight loss (16% to 22%) compared to Saxenda (8%), making them two of the most discussed medications in decades
Enhertu (Trastuzumab deruxtecan) from Daiichi Sankyo and AstraZeneca has quarterly sales over $1 billion and is projected to reach $5 billion in 2025
Refrigeration at this range slows molecular degradation and helps maintain the peptide's three-dimensional structure, which is critical for receptor binding and pharmacological activity
For a closer look at the mission behind the brand, read Giving Back to Veterans & Our Communities
Praise for Becky Dorner & Associates The Science of Super-Aging: Unlocking the Secrets of Longevity Kathleen Pellechia, MS, RDN, PMP A Comprehensive Guide to Clinical Nutrition Care 20 CPE Self-Study Course Erin Allen, MS, RDN, LD A Dietitians Guide to Medications for Patients with Diabetes 12th Edition Self-Study Course Casey Seiden, MS, RDN, CDN, CDE Alcohol Use, Heart Health and Cancer Risk: A Review of the Evidence Kathleen Pellechia, MS, RDN Beyond BMI: Reframing Obesity Emma Fogt, MBA, MS, RDN, LDN, FAND The MIND Diet for Brain Health Course Emma Fogt, EdD, MBA, MS, RDN, LDN, FAND
